中樞性尿崩癥患者滲透性脫髓鞘綜合征一例_West China Medical Journal

Authors：

陳尚韜 ¹ , 趙敏君 ² , 安振梅 ³ ,  李雙慶 ¹

1. ;
2. ;
3. ;

Corresponding?author：

李雙慶, Email: 1259594471@qq.com

Keywords：

尿崩癥; 滲透性脫髓鞘; 個案

DOI：

10.7507/1002-0179.202206021

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 陳尚韜, 趙敏君, 安振梅, 李雙慶. 中樞性尿崩癥患者滲透性脫髓鞘綜合征一例. West China Medical Journal, 2022, 37(11): 1757-1760. doi: 10.7507/1002-0179.202206021 Copy

1.	Adams RD, Victor M, Mancall EL. Central pontine myelinolysis: a hitherto undescribed disease occurring in alcoholic and malnourished patients. AMA Arch Neurol Psychiatry, 1959, 81(2): 154-172.
2.	Sterns RH. Treatment of severe hyponatremia. Clin J Am Soc Nephrol, 2018, 13(4): 641-649.
3.	de Souza A, Desai PK. More often striatal myelinolysis than pontine? A consecutive series of patients with osmotic demyelination syndrome. Neurol Res, 2012, 34(3): 262-271.
4.	Hoshino Y, Odaka M, Hirata K. Pontine hemorrhage in a patient with type 1 renal tubular acidosis associated with osmotic demyelination syndrome. Brain Nerve, 2008, 60(9): 1061-1065.
5.	Hirosawa T, Shimizu T. Osmotic demyelination syndrome due to hyperosmolar hyperglycemia. Cleve Clin J Med, 2018, 85(7): 511-513.
6.	Crismale JF, Meliambro KA, DeMaria S Jr, et al. Prevention of the osmotic demyelination syndrome after liver transplantation: a multidisciplinary perspective. Am J Transplant, 2017, 17(10): 2537-2545.
7.	王寒, 羅淼, 陳璐, 等. 高齡中樞性尿崩癥合并嚴重高鈉血癥 1 例并文獻復習. 中國臨床研究, 2022, 35(4): 543-545.
8.	Garrahy A, Moran C, Thompson CJ. Diagnosis and management of central diabetes insipidus in adults. Clin Endocrinol (Oxf), 2019, 90(1): 23-30.
9.	Mutter CM, Smith T, Menze O, et al. Diabetes insipidus: pathogenesis, diagnosis, and clinical management. Cureus, 2021, 13(2): e13523.
10.	Simerville JA, Maxted WC, Pahira JJ. Urinalysis: a comprehensive review. Am Fam Physician, 2005, 71(6): 1153-1162.
11.	Levy M, Prentice M, Wass J. Diabetes insipidus. BMJ, 2019, 364: 1321.
12.	Ayus JC, Armstrong DL, Arieff AI. Effects of hypernatraemia in the central nervous system and its therapy in rats and rabbits. J Physiol, 1996, 492(Pt1): 243-255.
13.	Ashrafian H, Davey P. A review of the causes of central pontine myelinosis: yet another apoptotic illness?. Eur J Neurol, 2001, 8(2): 103-109.
14.	Miller GM, Baker HL Jr, Okazaki H, et al. Central pontine myelinolysis and its imitators: MR findings. Radiology, 1988, 168(3): 795-802.
15.	Ruzek KA, Campeau NG, Miller GM. Early diagnosis of central pontine myelinolysis with diffusion-weighted Imaging. AJNR Am J Neuroradiol, 2004, 25(2): 210-213.
16.	Alleman AM. Osmotic demyelination syndrome: central pontine myelinolysis and extrapontine myelinolysis. Semin Ultrasound CT MR, 2014, 35(2): 153-159.
17.	陳柳靜, 楊楠, 王本國, 等. 腦橋中央和腦橋外髓鞘溶解癥的臨床與影像學特征. 中國神經精神疾病雜志, 2011, 37(8): 498-500.
18.	李茹, 田晉生, 王建紅, 等. 低鈉血癥伴腦橋中央髓鞘溶解癥 1 例報道. 中西醫結合心腦血管病雜志, 2021, 19(20): 3627-3629.
19.	張希軍, 李超, 王釗, 等. 快速糾正腸梗阻低鈉血癥致滲透性脫髓鞘綜合征 1 例 MRI 表現并文獻復習. 影像研究與醫學應用, 2020, 4(13): 230-231.
20.	李俊敏, 彭濤, 付振強, 等. 滲透性脫髓鞘綜合征 9 例臨床分析. 中國實用神經疾病雜志, 2019, 22(10): 1045-1051.
21.	Liamis G, Filippatos TD, Elisaf MS. Evaluation and treatment of hypernatremia: a practical guide for physicians. Postgrad Med, 2016, 128(3): 299-306.
22.	Alkali NH, Jibrin YB, Dunga JA, et al. Osmotic demyelination syndrome following acute kidney injury with hypernatremia. Niger J Clin Pract, 2019, 22(8): 1166-1168.
23.	Nelson NR, Tompkins MG, Thompson Bastin ML. Plasma exchange as treatment for osmotic demyelination syndrome: case report and review of current literature. Transfus Apher Sci, 2019, 58(6): 102663.
24.	Rodriguez M, Miller DJ, Lennon VA. Immunoglobulins reactive with myelin basic protein promote CNS remyelination. Neurology, 1996, 46(2): 538-545.
25.	Zheng C, Chen G, Tan Y, et al. TRH analog, taltirelin improves motor function of hemi-PD rats without inducing dyskinesia via sustained dopamine stimulating effect. Front Cell Neurosci, 2018, 12: 417.
26.	漆黎明, 汪萌芽. TRH 對離體脊髓內在調控運動神經元通路的影響. 皖南醫學院學報, 2022, 41(1): 5-9.
27.	Silver SM, Schroeder BM, Sterns RH, et al. Myoinositol administration improves survival and reduces myelinolysis after rapid correction of chronic hyponatremia in rats. J Neuropathol Exp Neurol, 2006, 65(1): 37-44.
28.	李倩, 高杰, 胡蓉, 等. 磷脂酰肌醇-3 激酶/蛋白激酶 B/FoxO1 信號通路和白細胞介素 17 在小鼠實驗性自身免疫性腦脊髓炎中的表達變化. 解剖學報, 2021, 52(3): 358-364.
29.	Takefuji S, Murase T, Sugimura Y, et al. Role of microglia in the pathogenesis of osmotic-induced demyelination. Exp Neurol, 2007, 204(1): 88-94.
30.	Peng Y, Zhang X, Zhang T, et al. Lovastatin inhibits Toll-like receptor 4 signaling in microglia by targeting its co-receptor myeloid differentiation protein 2 and attenuates neuropathic pain. Brain Behav Immun, 2019, 82: 432-444.
31.	Takagi H, Sugimura Y, Suzuki H, et al. Minocycline prevents osmotic demyelination associated with aquaresis. Kidney Int, 2014, 86(5): 954-964.

1. Adams RD, Victor M, Mancall EL. Central pontine myelinolysis: a hitherto undescribed disease occurring in alcoholic and malnourished patients. AMA Arch Neurol Psychiatry, 1959, 81(2): 154-172.
2. Sterns RH. Treatment of severe hyponatremia. Clin J Am Soc Nephrol, 2018, 13(4): 641-649.
3. de Souza A, Desai PK. More often striatal myelinolysis than pontine? A consecutive series of patients with osmotic demyelination syndrome. Neurol Res, 2012, 34(3): 262-271.
4. Hoshino Y, Odaka M, Hirata K. Pontine hemorrhage in a patient with type 1 renal tubular acidosis associated with osmotic demyelination syndrome. Brain Nerve, 2008, 60(9): 1061-1065.
5. Hirosawa T, Shimizu T. Osmotic demyelination syndrome due to hyperosmolar hyperglycemia. Cleve Clin J Med, 2018, 85(7): 511-513.
6. Crismale JF, Meliambro KA, DeMaria S Jr, et al. Prevention of the osmotic demyelination syndrome after liver transplantation: a multidisciplinary perspective. Am J Transplant, 2017, 17(10): 2537-2545.
7. 王寒, 羅淼, 陳璐, 等. 高齡中樞性尿崩癥合并嚴重高鈉血癥 1 例并文獻復習. 中國臨床研究, 2022, 35(4): 543-545.
8. Garrahy A, Moran C, Thompson CJ. Diagnosis and management of central diabetes insipidus in adults. Clin Endocrinol (Oxf), 2019, 90(1): 23-30.
9. Mutter CM, Smith T, Menze O, et al. Diabetes insipidus: pathogenesis, diagnosis, and clinical management. Cureus, 2021, 13(2): e13523.
10. Simerville JA, Maxted WC, Pahira JJ. Urinalysis: a comprehensive review. Am Fam Physician, 2005, 71(6): 1153-1162.
11. Levy M, Prentice M, Wass J. Diabetes insipidus. BMJ, 2019, 364: 1321.
12. Ayus JC, Armstrong DL, Arieff AI. Effects of hypernatraemia in the central nervous system and its therapy in rats and rabbits. J Physiol, 1996, 492(Pt1): 243-255.
13. Ashrafian H, Davey P. A review of the causes of central pontine myelinosis: yet another apoptotic illness?. Eur J Neurol, 2001, 8(2): 103-109.
14. Miller GM, Baker HL Jr, Okazaki H, et al. Central pontine myelinolysis and its imitators: MR findings. Radiology, 1988, 168(3): 795-802.
15. Ruzek KA, Campeau NG, Miller GM. Early diagnosis of central pontine myelinolysis with diffusion-weighted Imaging. AJNR Am J Neuroradiol, 2004, 25(2): 210-213.
16. Alleman AM. Osmotic demyelination syndrome: central pontine myelinolysis and extrapontine myelinolysis. Semin Ultrasound CT MR, 2014, 35(2): 153-159.
17. 陳柳靜, 楊楠, 王本國, 等. 腦橋中央和腦橋外髓鞘溶解癥的臨床與影像學特征. 中國神經精神疾病雜志, 2011, 37(8): 498-500.
18. 李茹, 田晉生, 王建紅, 等. 低鈉血癥伴腦橋中央髓鞘溶解癥 1 例報道. 中西醫結合心腦血管病雜志, 2021, 19(20): 3627-3629.
19. 張希軍, 李超, 王釗, 等. 快速糾正腸梗阻低鈉血癥致滲透性脫髓鞘綜合征 1 例 MRI 表現并文獻復習. 影像研究與醫學應用, 2020, 4(13): 230-231.
20. 李俊敏, 彭濤, 付振強, 等. 滲透性脫髓鞘綜合征 9 例臨床分析. 中國實用神經疾病雜志, 2019, 22(10): 1045-1051.
21. Liamis G, Filippatos TD, Elisaf MS. Evaluation and treatment of hypernatremia: a practical guide for physicians. Postgrad Med, 2016, 128(3): 299-306.
22. Alkali NH, Jibrin YB, Dunga JA, et al. Osmotic demyelination syndrome following acute kidney injury with hypernatremia. Niger J Clin Pract, 2019, 22(8): 1166-1168.
23. Nelson NR, Tompkins MG, Thompson Bastin ML. Plasma exchange as treatment for osmotic demyelination syndrome: case report and review of current literature. Transfus Apher Sci, 2019, 58(6): 102663.
24. Rodriguez M, Miller DJ, Lennon VA. Immunoglobulins reactive with myelin basic protein promote CNS remyelination. Neurology, 1996, 46(2): 538-545.
25. Zheng C, Chen G, Tan Y, et al. TRH analog, taltirelin improves motor function of hemi-PD rats without inducing dyskinesia via sustained dopamine stimulating effect. Front Cell Neurosci, 2018, 12: 417.
26. 漆黎明, 汪萌芽. TRH 對離體脊髓內在調控運動神經元通路的影響. 皖南醫學院學報, 2022, 41(1): 5-9.
27. Silver SM, Schroeder BM, Sterns RH, et al. Myoinositol administration improves survival and reduces myelinolysis after rapid correction of chronic hyponatremia in rats. J Neuropathol Exp Neurol, 2006, 65(1): 37-44.
28. 李倩, 高杰, 胡蓉, 等. 磷脂酰肌醇-3 激酶/蛋白激酶 B/FoxO1 信號通路和白細胞介素 17 在小鼠實驗性自身免疫性腦脊髓炎中的表達變化. 解剖學報, 2021, 52(3): 358-364.
29. Takefuji S, Murase T, Sugimura Y, et al. Role of microglia in the pathogenesis of osmotic-induced demyelination. Exp Neurol, 2007, 204(1): 88-94.
30. Peng Y, Zhang X, Zhang T, et al. Lovastatin inhibits Toll-like receptor 4 signaling in microglia by targeting its co-receptor myeloid differentiation protein 2 and attenuates neuropathic pain. Brain Behav Immun, 2019, 82: 432-444.
31. Takagi H, Sugimura Y, Suzuki H, et al. Minocycline prevents osmotic demyelination associated with aquaresis. Kidney Int, 2014, 86(5): 954-964.

Previous Article
坐位胸段硬膜外穿刺時突發嚴重低血壓一例

West China Medical Journal

中樞性尿崩癥患者滲透性脫髓鞘綜合征一例

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Format

Content